Gauzy disclosed Nasdaq notified it is non-compliant due to late 2025 Form 20-F filing and a separate minimum bid-price rule. The stock will trade normally, but Gauzy must file a compliance plan within 60 days and could receive up to 180 days extension if approved, risking delisting if not. No immediate business impact is expected, though liquidity and sentiment may deteriorate.
Immediate trading continues, but non-compliance creates delisting risk and liquidity concerns; likely short-term volatility with uncertain price direction until a plan is approved.
Near-term GAUZ trading is likely choppy until Nasdaq approves a plan and 20-F filing; resolution could stabilize stock within months.
Regulatory/Legal update on listing compliance; fits Corporate Developments with legal risk.